Open Access

Live Q&A.

Topic: Biomarkers
Sponsored by Roche Diagnostics International Ltd

Presentation

5 more presentations in this session

Introduction.

Speaker: Doctor A. Bayes Genis (Badalona, ES)

Thumbnail

The value of NT-proBNP in heart failure Risk Stratification and Optimization of Cardioprotective Treatment among Patients with Type 2 Diabetes.

Speaker: Professor C. Lam (Singapore, SG)

Thumbnail

Improve access to heart failure diagnostic services, using biomarkers, innovative digital and artificial intelligence techniques.

Speaker: Professor M. Petrie (Glasgow, GB)

Thumbnail

The value of biomarkers in personalized discharge planning supporting optimized post-discharge management.

Speaker: Doctor J. Tromp (Singapore, SG)

Thumbnail

The value of NT-proBNP outpatient monitoring for predicting myocardial remodeling and its reversal.

Speaker: Professor J. Januzzi (Boston, US)

Thumbnail

Access the full session

The value of cardiac biomarkers in optimized heart failure patient management

Speakers: Doctor A. Bayes Genis, Professor C. Lam, Professor M. Petrie, Doctor J. Tromp, Professor J. Januzzi
Thumbnail

About the event

Image

Heart Failure 2021 Online Congress

29 June - 1 July 2021

Sessions Presentations

Related content

Open Access

A curated selection of highlights

24 October 2021

Open Access

Introduction.

24 October 2021

ESC Premium Access

An asymptomatic patient with positive treadmill test during screening for life insurance and significant proximal LAD disease in coronary CT angiography: what do the guidelines say?

27 August 2021

This platform is supported by

logo Novo Nordisk